ICD-10 Coding for ESBL Infections(A41.5, A41.5N, A41.5S)
Learn about coding ESBL infections using ICD-10 codes, including Z16.12 for ESBL resistance. Understand documentation requirements and coding pitfalls.
Complete code families applicable to ESBL Infections
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z16.12 | Resistance to extended-spectrum beta-lactamase (ESBL) | Use when ESBL resistance is confirmed by lab tests and documented in the patient's record. |
|
| A41.5 | Sepsis due to Gram-negative organism | Use when sepsis is confirmed and linked to an ESBL-producing organism. |
|
| N39.0 | Urinary tract infection, site not specified | Use for UTIs confirmed to be caused by ESBL-producing organisms. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutESBL Infections
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting ESBL Infections.
Using Z16.12 without specifying the organism
Impact
Clinical: Leads to inappropriate treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential claim rejections.
Mitigation
Always document the specific organism., Review lab reports before coding.
Incorrect sequencing of Z16.12 with primary infection codes
Impact
Reimbursement: Incorrect sequencing can lead to claim denials., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate data on antimicrobial resistance.
Mitigation
Always sequence Z16.12 after the primary infection code.
Antimicrobial resistance coding
Impact
Incorrect coding of antimicrobial resistance can lead to audits.
Mitigation
Ensure all resistance is lab-confirmed and documented.